23 assets in Adult Glioblastoma

Therapeutic assets addressing Adult Glioblastoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cediranib Adult Glioblastoma	Lawrence Recht	P2	BBB (73)
Irinotecan Adult Glioblastoma	NaviFUS Corporation	P3	BB (70)
Vorinostat Adult Glioblastoma	National Cancer Institute (NCI)	P2	BB (68)
Lomustine Adult Glioblastoma	Telix Pharmaceuticals (Innovations) Pty Limited	P3	BB (64)
Microbubble Adult Glioblastoma	NaviFUS Corporation	P3	B (60)
Tlx-101-Tx Adult Glioblastoma	Telix Pharmaceuticals (Innovations) Pty Limited	P3	B (60)
Pembrolizumab Adult Glioblastoma	University Hospital, Geneva	P1/2	B (57)
Camustine Adult Glioblastoma	Leland Metheny	P2	CCC (53)
Nivestim Adult Glioblastoma	Leland Metheny	P2	CCC (53)
o6-benzylguanine Adult Glioblastoma	Leland Metheny	P2	CCC (53)
p140k-mgmt Adult Glioblastoma	Leland Metheny	P2	CCC (53)
Ruxolitinib Adult Glioblastoma	Baptist Health South Florida	P2	CCC (53)
Capecitabine Adult Glioblastoma	Northwell Health	P1/2	CCC (48)
Oxaliplatin Adult Glioblastoma	Northwell Health	P1/2	CCC (48)
Belzutifan Adult Glioblastoma	Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	P1	CC (43)
cs231295 Adult Glioblastoma	Chipscreen Biosciences, Ltd.	P1	CC (43)
Pitavastatin Adult Glioblastoma	C.Dirven	Early P1	CC (43)
Sapanisertib Adult Glioblastoma	National Cancer Institute (NCI)	P1	CC (43)
Umitrelimorgene Autodencel Human Lysosomal Associated Membrane Protein 1/Human Cytomegalovirus (Hcmv) 65 Kda Matrix Protein Mrna Adult Glioblastoma	University of Florida	P1	CC (43)
Berubicin Adult Glioblastoma	CNS Pharmaceuticals, Inc.	P2	C (39)
Ketoconazole Adult Glioblastoma	Milton S. Hershey Medical Center	Early P1	C (39)
Posaconazole Adult Glioblastoma	Milton S. Hershey Medical Center	Early P1	C (39)
TIL Adult Glioblastoma	Hebei Senlang Biotechnology Inc., Ltd.	Early P1	C (39)